i think than moses hazen was quite frankly. i i see hazen as the pugilist. he was always really rather irritating as an individual from what i can see i think his commanding officer. saw him that certainly general knox at the end of it said that this was a man who was blessed with one of the most obstinate tempers he had ever seen. but it was the kind of temper that meant that this regiment continued in action through the rest of the war. but given this it starts going out for recruiting for congress's own so you can see what's going on here. you can't recruit for second canadian among all of them, but you can for congress's own guard here. it's got elite status. this sounds really good. this is better than just simply what the first pennsylvania really the first video. why not congress's own and they did tremendously. well this regiment was authorized a thousand men so much bigger than the common continental infantry regiment, but it was authorized a thousand and by this spring of 77. it was hitting close to 900 men had enlisted in this regiment now did the

joining us now is ellen hazen, fl putnam investment management portfolio manager.en: we don't think that is going to be the case. you have ukraine, omicron, inflation. those things paint a very mixed picture indeed. guy: what are you going to be doing in february given that backdrop, even the potential for cigna can volatility? how are you repurchasing that for significant volatility -- for significant volatility? how are you repurpose in the portfolio for that? ellen: please volatility will give you an opportunity at cheaper prices. we are looking at companies that can benefit from higher gdp growth, so looking at financials, materials, and looking at companies that have pricing power, and we are looking to get involved at more attractive prices. but february is likely to be a bouncy ride. kailey: are you buying the dips or selling the reps -- the rips? ellen: we are doing both. we are seeing the growth beneficiaries really begin to get the wind taken out of their sales, so the very expensive growth names that had high valuations are probably done for, at least fo